The domestic patent for Keytruda, the world’s top-selling medicine by annual sales, is scheduled to expire in 2028. A fierce ...

Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...

Politics latest: Farage denies rule breach after reportedly failing to declare benefits from an ally Nigel Farage's spokesperson has denied allegations that the Reform leader could be in breach of ...